The pharmaceutical industry in Belgium - Competitiveness analysis [09/05/2019]

This Working Paper analyses the competitive position of the pharmaceutical industry over the 2000-2017 period. The evolution of price/cost competitiveness and non-cost competitiveness is studied based on a comparison with our neighbouring countries France, the Netherlands and Germany, and with Denmark, Ireland, Slovenia and Switzerland. The study also analyses a series of global factors and factors specific to the pharmaceutical industry that may influence competitiveness.

Tax incentives for business R&D in Belgium - Third evaluation [07/05/2019]

Belgium has committed to raise investment in research and development (R&D) to 3% of GDP by 2020. In fulfilment of this commitment, the federal government introduced different tax incentives in support of business R&D. This paper presents the results of the third evaluation of the efficiency of these tax incentives, covering the period 2003-2015.

Value chain integration of export-oriented and domestic market manufacturing firms - An analysis based on a heterogeneous input-output table for Belgium [26/09/2018]

This working paper presents a breakdown of manufacturing industries in the 2010 Belgian input-output tables into export-oriented and domestic market firms. Analyses based on these tables show that export-oriented manufacturers generate a substantial amount of value added in other Belgian firms through their exports. Hence, in terms of policy, export promotion must take into account the value chain for producing exports.